Tech2Heal SAS announced that it has entered into agreement with AI/ML Innovations Inc. in a round of funding on July 28, 2021. The transaction include participation form AI/ML Innovations Inc. Post completion of the transaction the investor will hold 22.22% stake. investor will hold a permanent seat on the board of directors of the company.

The closing of the transaction is subject to satisfactory completion of due diligence by investor, investor board approval, any requisite regulatory approval including but not limited to the approval of the CSE, and other conditions typically set out in a purchase and sale agreement of this type. The parties are working to complete a definitive agreement based upon the terms found of letter of intent on or about July 15, 2021. investor acquires an undivided interest in the company global operations by way of a €2 million total investment, in return for 22.22% common share equity.

investor advanced €750,000 in conjunction with the closing of the transaction, with an additional €250,000 due on the 6-month anniversary, €500,000 due on the 12-month anniversary, and a final €500,000 due on the 18-month anniversary of the closing of the transaction.